|
1
|
Bacci G, Longhi A, Fagioli F, et al:
Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the
extremities: 27 year experience at Rizzoli Institute, Italy. Eur J
Cancer. 41:2836–2845. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chou AJ, Geller DS and Gorlick R: Therapy
for osteosarcoma: Where do we go from here? Pediatric Drugs.
10:315–327. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bacci G, Longhi A, Versari M, et al:
Prognostic factors for osteosarcoma of the extremity treated with
neoadjuvant chemotherapy: 15-year experience in 789 patients
treated at a single institute. Cancer. 106:1154–1161. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma. Cancer Treat Res. 152:3–13. 2009.
|
|
5
|
Dang CV and Semenza GL: Oncogenic
alterations of metabolism. Trends Biochem Sci. 24:68–72. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rohwer N, Zasada C, Kempa S and Cramer T:
The growing complexity of HIF-1α′s role in tumorigenesis: DNA
repair and beyond. Oncogene. 32:3569–3576. 2013. View Article : Google Scholar
|
|
7
|
Blancher C and Harris AL: The molecular
basis of the hypoxia response pathway: Tumour hypoxia as a therapy
target. Cancer Metastasis Rev. 17:187–194. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wilson WR and Hay MP: Targeting hypoxia in
cancer therapy. Nat Rev Cancer. 11:393–410. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim JY, Kang JS, Kim HM, et al: Inhibition
of phenotypic and functional maturation of dendritic cells by
manassantin a. J Pharmacol Sci. 109:583–592. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim SJ, Lu Y, Kwon O, et al: Manassantin A
isolated from Saururus chinensis inhibits 5-lipoxygenase-dependent
leukotriene C4 generation by blocking mitogen-activated protein
kinase activation in mast cells. Biol Pharm Bull. 34:1769–1772.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kasper AC, Moon EJ, Hu X, et al: Analysis
of HIF-1 inhibition by manassantin A and analogues with modified
tetrahydrofuran configurations. Bioorg Med Chem Lett. 19:3783–3786.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hahm JC, Lee IK, Kang WK, et al:
Cytotoxicity of neolignans identified in Saururus chinensis towards
human cancer cell lines. Planta Med. 71:464–469. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rapisarda A, Uranchimeg B, Scudiero DA, et
al: Identificantion of small molecule inhibitors of
hypoxia-inducible factor 1 transcriptional activation pathway.
Cancer Res. 62:4316–4324. 2002.PubMed/NCBI
|
|
14
|
Lu C, Liu D, Jin J, et al: Inhibition of
gastric tumor growth by a novel Hsp90 inhibitor. Biochem Pharmacol.
85:1246–1256. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou Q, Li Y, Jin J, et al: Lx2–32c, a
novel taxane derivative, exerts anti-resistance activity by
initiating intrinsic apoptosis pathway in vitro and inhibits the
growth of resistant tumor in vivo. Biol Pharm Bull. 35:2170–2179.
2012. View Article : Google Scholar
|
|
16
|
Heymann D and Redini F: Bone sarcomas:
Pathogenesis and new therapeutic approaches. IBMS BoneKey.
8:402–414. 2011. View
Article : Google Scholar
|
|
17
|
Gobin B, Moriceau G, Ory B, et al:
Imatinib mesylate exerts anti-proliferative effects on osteosarcoma
cells and inhibits the tumour growth in immunocompetent murine
models. PLoS One. 9:e907952014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kwon OE, Lee HS, Lee SW, et al:
Manassantin A and B isolated from Saururus chinensis inhibt
TNF-alpha-induced cell adhesion molecule expression of human
umbilical vein endothelial cells. Arch Pharm Res. 28:55–60. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lang L, Liu X, Li Y, et al: A synthetic
manassantin A derivative inhibits hypoxia-inducible factor 1 and
tumor growth. PloS One. 9:e995842014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou J and Tang XC: Huperzine A attenuates
apoptosis and mitochondria-dependent caspase-3 in rat cortical
neurons. FEBS Lett. 526:21–25. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang Z, Lu W, Li Y and Tang B: Alpinetin
promotes Bax translo-cation, induces apoptosis through the
mitochondrial pathway and arrests human gastric cancer cells at the
G2/M phase. Mol Med Rep. 7:915–920. 2013.
|
|
22
|
Lee CS, Han JH, Jang YY, et al:
Differential effect of catecholamines and MPP(+) on membrane
permeability in brain mitochondria and cell viability in PC12
cells. Neurochem Int. 40:361–369. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yuan J, Adamski R and Chen J: Focus on
histone variant H2AX: To be or not to be. FEBS Lett. 584:3717–3724.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang C and Youle RJ: The role of
mitochondria in apoptosis. Annu Rev Genet. 43:95–118. 2009.
View Article : Google Scholar
|
|
25
|
Gannavaram S and Debrabant A: Programmed
cell death in Leishmania: Biochemical evidence and role in parasite
infectivity. Front Cell Infect Microbiol. 2:952012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu XY, Xu KD, Yan M, et al: Protective
effects of galantamine against Abeta-induced PC12 cell apoptosis by
preventing mitochondrial dysfunction and endoplasmic reticulum
stress. Neurochem Int. 57:588–599. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kabeer FA, Sreedevi GB, Nair MS, et al:
Isodeoxyelephantopin from Elephantopus scaber (Didancao) induces
cell cycle arrest and caspase-3-mediated apoptosis in breast
carcinoma T47D cells and lung carcinoma A549 cells. Chin Med.
9:142014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Stratford EW, Daffinrud J, Munthe E, et
al: The tankyrase-specific inhibitor JW74 affects cell cycle
progression and induces apoptosis and differentiation in
osteosarcoma cell lines. Cancer Med. 3:36–46. 2014. View Article : Google Scholar : PubMed/NCBI
|
